A phase I trial of intracranial dendritic cell immunotherapy for patients with malignant glioma

被引：0
|
作者：
Yu, John S.
Liu, Gentao
Ng, Hiushan
Wagenberg, Mia
Luptrawan, Anne
Mindlin, Elina
Wheeler, Christopher J.
Black, Keith L.
机构：
来源：
NEUROSURGERY | 2006年 / 59卷 / 02期
关键词：
D O I：
10.1227/00006123-200608000-00132
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [31] A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma
    Desjardins, Annick
    Reardon, David A.
    Peters, Katherine B.
    Threatt, Stevie
    Coan, April D.
    Herndon, James E., II
    Friedman, Allan H.
    Friedman, Henry S.
    Vredenburgh, James J.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 105 (03) : 601 - 606
  • [32] Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma
    Friedman, HS
    Kokkinakis, DM
    Pluda, J
    Friedman, AH
    Cokgor, I
    Haglund, MM
    Ashley, DM
    Rich, J
    Dolan, ME
    Pegg, AE
    Moschel, RC
    McLendon, RE
    Kerby, T
    Herndon, JE
    Bigner, DD
    Schold, SC
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) : 3570 - 3575
  • [33] A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma
    Reardon, David A.
    Groves, Morris D.
    Wen, Patrick Y.
    Nabors, Louis
    Mikkelsen, Tom
    Rosenfeld, Steve
    Raizer, Jeffrey
    Barriuso, Jorge
    McLendon, Roger E.
    Suttle, A. Benjamin
    Ma, Bo
    Curtis, C. Martin
    Dar, Mohammed M.
    de Bono, Johann
    CLINICAL CANCER RESEARCH, 2013, 19 (04) : 900 - 908
  • [34] A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma
    Annick Desjardins
    David A. Reardon
    Katherine B. Peters
    Stevie Threatt
    April D. Coan
    James E. Herndon
    Allan H. Friedman
    Henry S. Friedman
    James J. Vredenburgh
    Journal of Neuro-Oncology, 2011, 105 : 601 - 606
  • [35] Phase I trial of bortezomib in adults with recurrent malignant glioma.
    Phuphanich, S.
    Supko, J.
    Carson, K. A.
    Grossman, S. A.
    Nabors, L. B.
    Mikkelsen, T.
    Lesser, G.
    Rosenfeld, M.
    Desideri, S.
    Olson, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 74S - 74S
  • [36] PHASE I TRIAL OF TEMSIROLIMUS AND PERIFOSINE FOR RECURRENT OR PROGRESSIVE MALIGNANT GLIOMA
    Lassman, Andrew B.
    Kaley, Thomas J.
    DeAngelis, Lisa M.
    Hormigo, Adilia
    Mellinghoff, Ingo K.
    Otap, Daniel D.
    Seger, Jennifer
    Doyle, L. A.
    Ludwig, Emmy
    Lacouture, Mario E.
    Panageas, Katherine S.
    NEURO-ONCOLOGY, 2011, 13 : 90 - 90
  • [37] Phase I dose escalation study of autologous tumor lysate-pulsed dendritic cell immunotherapy for malignant gliomas in pediatric patients
    Lasky, Joseph
    Liau, Linda
    Prins, Robert
    Moore, Theodore
    NEURO-ONCOLOGY, 2008, 10 (03) : 426 - 426
  • [38] Dendritic cell vaccine for intracranial tumors I (DC Victori trial)
    Archer, GE
    Bigner, D
    Friedman, A
    Friedman, H
    Penne, K
    Lally-Batts, D
    Paolino, A
    Tourt-Uhlig, S
    Reardon, D
    Sampson, J
    NEURO-ONCOLOGY, 2004, 6 (04) : 341 - 341
  • [39] PRELIMINARY CLINICAL-TRIAL OF IMMUNOTHERAPY FOR MALIGNANT GLIOMA
    INGRAM, M
    SHELDEN, CH
    JACQUES, S
    SKILLEN, RG
    BRADLEY, WG
    TECHY, GB
    FRESHWATER, DB
    ABTS, RM
    RAND, RW
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1987, 6 (05): : 489 - 498
  • [40] A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma
    Midgley, R.
    Kerr, D. J.
    Palmer, D.
    Mirza, N.
    Milner, A.
    Adams, D.
    ANNALS OF ONCOLOGY, 2004, 15 : 101 - 102
12345